Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections

Carbapenem-resistant Acinetobacter species are increasingly recognized as major nosocomial pathogens, especially in patients with critical illnesses or in intensive care. The ability of these organisms to accumulate diverse mechanisms of resistance limits the available therapeutic agents, makes the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Uh Jin, Kim, Hee Kyung, An, Joon Hwan, Cho, Soo Kyung, Park, Kyung-Hwa, Jang, Hee-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161759/
https://www.ncbi.nlm.nih.gov/pubmed/25229014
http://dx.doi.org/10.4068/cmj.2014.50.2.37
_version_ 1782334595782410240
author Kim, Uh Jin
Kim, Hee Kyung
An, Joon Hwan
Cho, Soo Kyung
Park, Kyung-Hwa
Jang, Hee-Chang
author_facet Kim, Uh Jin
Kim, Hee Kyung
An, Joon Hwan
Cho, Soo Kyung
Park, Kyung-Hwa
Jang, Hee-Chang
author_sort Kim, Uh Jin
collection PubMed
description Carbapenem-resistant Acinetobacter species are increasingly recognized as major nosocomial pathogens, especially in patients with critical illnesses or in intensive care. The ability of these organisms to accumulate diverse mechanisms of resistance limits the available therapeutic agents, makes the infection difficult to treat, and is associated with a greater risk of death. In this review, we provide an update on the epidemiology, resistance mechanisms, infection control measures, treatment, and outcomes of carbapenem-resistant Acinetobacter infections.
format Online
Article
Text
id pubmed-4161759
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Chonnam National University Medical School
record_format MEDLINE/PubMed
spelling pubmed-41617592014-09-16 Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections Kim, Uh Jin Kim, Hee Kyung An, Joon Hwan Cho, Soo Kyung Park, Kyung-Hwa Jang, Hee-Chang Chonnam Med J Review Article Carbapenem-resistant Acinetobacter species are increasingly recognized as major nosocomial pathogens, especially in patients with critical illnesses or in intensive care. The ability of these organisms to accumulate diverse mechanisms of resistance limits the available therapeutic agents, makes the infection difficult to treat, and is associated with a greater risk of death. In this review, we provide an update on the epidemiology, resistance mechanisms, infection control measures, treatment, and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam National University Medical School 2014-08 2014-08-20 /pmc/articles/PMC4161759/ /pubmed/25229014 http://dx.doi.org/10.4068/cmj.2014.50.2.37 Text en © Chonnam Medical Journal, 2014 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kim, Uh Jin
Kim, Hee Kyung
An, Joon Hwan
Cho, Soo Kyung
Park, Kyung-Hwa
Jang, Hee-Chang
Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
title Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
title_full Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
title_fullStr Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
title_full_unstemmed Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
title_short Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
title_sort update on the epidemiology, treatment, and outcomes of carbapenem-resistant acinetobacter infections
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161759/
https://www.ncbi.nlm.nih.gov/pubmed/25229014
http://dx.doi.org/10.4068/cmj.2014.50.2.37
work_keys_str_mv AT kimuhjin updateontheepidemiologytreatmentandoutcomesofcarbapenemresistantacinetobacterinfections
AT kimheekyung updateontheepidemiologytreatmentandoutcomesofcarbapenemresistantacinetobacterinfections
AT anjoonhwan updateontheepidemiologytreatmentandoutcomesofcarbapenemresistantacinetobacterinfections
AT chosookyung updateontheepidemiologytreatmentandoutcomesofcarbapenemresistantacinetobacterinfections
AT parkkyunghwa updateontheepidemiologytreatmentandoutcomesofcarbapenemresistantacinetobacterinfections
AT jangheechang updateontheepidemiologytreatmentandoutcomesofcarbapenemresistantacinetobacterinfections

Ejemplares similares